Jointly organised by the Fund for Scientific Research-FNRS (F.R.S.-FNRS) and the Research Foundation Flanders (FWO)

The bottom-up, cross-European initiative called Weave was launched in December 2020 by European research funders to support excellent collaborative research projects across borders. By making proposals go through a single review process, Weave aims to simplify the submission and selection procedures of collaborative research proposals that involve researchers from up to three European countries or regions.

Weave is implemented through existing, bottom up, funding channels for fundamental research (with the corresponding timelines and conditions) in the participating funding agencies. Therefore, there are no additional restrictions on the thematic focus or subject.

The information session aims to reply to the following questions:

What is Weave, how does it work in practice? How can Weave facilitate scientific collaboration between researchers from the French-speaking community and Flanders? Which other bi- and trilateral collaborations are possible within Weave? What are the conditions, procedures and timelines to be followed?

We kindly invite you to the virtual info session on the 10^th of February 2025 from 2.00 pm (CET) onwards, during which the FWO and the F.R.S.-FNRS will present the collaboration opportunities within the Weave initiative and answer your questions during a Q&A session.

• Please register here
• Please note that you will receive the specific link to the Zoom webinar a few days before the info session. 
• For more information or questions, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. .

Specific webpages on Weave:

• Weave
• F.R.S.-FNRS
• FWO

It supports medical or biomedical research projects that are original, audacious, and creative but do not find support in traditional funding channels due to a lack of preliminary data, absence of prior work, or an unconventional methodology.

 

The AMG-ONCO is not a funding instrument dependent on Télévie, but the FNRS uses the expertise of its Scientific Committee to evaluate the submitted projects. Therefore, there is no overlap between the AMG-ONCO 2025 call and the Télévie 2025 call.

 

This call covers all areas of oncology and all approaches (biomedical research, clinical research, epidemiological research, public health…). The submitted project must aim to:

The AMG-ONCO 2025 call is open until February 27, 2025.

 

Mini-guide Audacious Medical Grant – Oncology (AMG-ONCO) 2025 FR / EN

 

• Mini-guide Télévie Call 2025
• Rules and Regulations Télévie (TLV)
• Rules and Regulations Télévie Research Project (PDR-TLV)
• Regulations Télévie Grant (only in FR)
• Regulations Télévie research assistant (only in FR)